CellaVision and Sysmex enhance partnership by signing a global distribution agreement
(Thomson Reuters ONE) -
CellaVision, which develops and sells digital morphology products for the
routine analysis of blood and other body fluids, extends and broadens
cooperation with Sysmex by entering a global distribution agreement. The
agreement gives Sysmex a non-exclusive right to sell CellaVision's products in
hematology laboratories worldwide.
"We extend our successful collaboration with Sysmex and enhance the agreement to
comprise more markets, including Japan, the country of origin for Sysmex
Corporation", says Yvonne Mårtensson, CEO of CellaVision. "Sysmex has the global
leadership position within hematology, and we are extremely pleased that they
continue to promote and sell our analyzers to their customers, providing us with
a very strong sales channel and the ability to carry on our market penetration.
Sysmex is the perfect partner and strategic match in our commitment to
strengthen our position as world leader within digital morphology analysis to
hematology laboratories."
Sysmex and CellaVision have been developing their partnership since 2001, when
they partnered in the European market. Sysmex Corporation, based in Kobe, Japan,
is a world leader in clinical laboratory testing for blood, urine and other
specimen. By adding CellaVision's products to their range, Sysmex can offer
their customers a complete line of automated laboratory instruments, that is to
say instruments for every step of the analytical process, from sample
preparation to cell counters and final assessment in CellaVision's analyzers.
Starting April 1, 2010, the non-exclusive agreement comprises all international
markets but Canada.
CellaVision continues to sell direct through its own sales organizations in the
Nordic countries, the US, Canada and Japan. In 2009, Europe accounted for 41% of
sales, North America for 55% and the rest of the world for 4%.
For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: + 708 33 77 82. E-mail: yvonne.martensson(at)cellavision.com
About Sysmex
Sysmex Corporation is a world leader in clinical laboratory systemization and
solutions, including laboratory diagnostics, laboratory automation and clinical
information systems. Serving customers for more than 42 years, Sysmex focuses
on technological leadership in diagnostic science and information tools that
make a real difference in the health of people worldwide. The company,
headquartered in Kobe, Japan, has subsidiaries in North America, Latin America,
Europe, China and Asia Pacific and employs more than 4,500 employees worldwide.
Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange. For
more information about Sysmex Corporation and its affiliate companies, please
visit www.sysmex.com
About CellaVision
CellaVision AB develops, markets, and sells market leading image analysis based
systems for routine analysis of blood and other body fluids. The company has a
core competence in development of software and hardware for automatic image
analysis of cells and cell changes for applications in health and medical care.
The company develops and markets systems for automatic differentials of white
blood cells and red morphology, and software for education and quality assurance
of differentials. The company's associates have expertise in advanced imaging
analysis, artificial intelligence, and automated microscopy.
The company headquarters are in Lund, Sweden. The company also has subsidiaries
in the US, Canada and Japan. For more information, visit www.cellavision.com
CellaVision's share is listed on First North Premier at the OMX Stockholm Stock
Exchange. The company's Certified Advisor is Remium AB.
[HUG#1395029]
Unternehmensinformation / Kurzprofil:
Datum: 18.03.2010 - 08:31 Uhr
Sprache: Deutsch
News-ID 17681
Anzahl Zeichen: 0
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 318 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision and Sysmex enhance partnership by signing a global distribution agreement"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
